NeuralCIM Information

Part 173 - July 28, 2026

A New Community and Resource for Alzheimer’s Patients Seeking Information About (also known as NeuroEPO)

By Greg | Founder & Fellow Patient

When I was diagnosed with early-stage Alzheimer’s disease in September 2025 at age 68, my world turned upside down - as it does for millions of families every year.

For eight months, I was on Lecanemab infusions through the care team at Duke Neurology. But as many patients experience with disease-modifying therapies, adverse side effects arose, and my doctors ultimately decided to take me off the drug.

If you are reading this, you might know the exact feeling that follows: the overwhelming urge to find something else. Like so many walking this path, I began searching for alternatives to slow disease progression, preserve cognitive function, and restore hope.

That search led me to NeuralCIM (NeuroEPO) - and ultimately, to creating NeuralCIM.info.

Why I Built NeuralCIM.info

When faced with an Alzheimer’s diagnosis, patients and caregivers are vulnerable. We live in a world where emerging medical opportunities can sometimes be overshadowed by bad actors looking to capitalize on desperation for financial gain.

I firmly believe that NeuralCIM is a neuroprotective therapy worth serious consideration for individuals in the early to mid-stages of Alzheimer’s. However, finding clear, unbiased, and reliable information about it shouldn’t require navigating sales pitches or misleading claims.

I created NeuralCIM.info as an independent, transparent community portal dedicated to sharing evidence-based information freely.

What You Can Expect Here:

• Real Community Experiences: Firsthand accounts and insights from current users.

• Grounding in Science: Summaries and analysis of clinical research published in reputable scientific journals.

• Vetted Resources: Clear guidance on reputable service providers, travel agents, and legitimate clinics.

• A Broad View of Care: Discussions covering both emerging therapies like NeuralCIM and standard non-amyloid symptomatic treatments (such as cholinesterase inhibitors).

Our Ethical Pledge & Guiding Principles

To ensure this platform remains a trusted space for everyone who visits, I am committing to three strict rules:

1. Always 100% Free Access: There will never be a paywall to access the information on NeuralCIM.info.

2. Zero Commercial Bias: I will never sell advertising space on this site, nor will I accept donations or sponsorships from anyone directly involved in the manufacturing or distribution of NeuralCIM.

3. Sustained by the Community: To cover hosting, software, and the significant time required to research and maintain this site, NeuralCIM.info relies entirely on voluntary community donations and official site merchandise available in our store.

Join the Conversation

This platform isn’t just about my story - it’s about building a safe, informative hub for all of us looking for answers. A community of people interested in NeuralCIM.

> Disclaimer: NeuralCIM.info is an independent patient advocacy and educational portal. The content provided on this site is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your neurologist or primary physician before starting or modifying any treatment plan.